Evolution Wealth Advisors, LLC Collegium Pharmaceutical, Inc Transaction History

Evolution Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$17.5 - $21.35 $3,692 - $4,504	-211 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$17.75 - $25.39 $5,697 - $8,150	-321 Reduced 60.34%	211 $4,000
Q1 2021 Apr 20, 2021	SELL	$19.25 - $26.1 $3,426 - $4,645	-178 Reduced 25.07%	532 $13,000
Q1 2020 Apr 22, 2020	BUY	$13.89 - $25.45 $9,861 - $18,069	710 New	710 $12,000

255

38.6M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.02B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.